VERCISE GEVIA - COFEPRIS Registration 63C2020 SSA
Access comprehensive regulatory information for VERCISE GEVIA (VERCISE GEVIA) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 63C2020 SSA and manufactured by BOSTON SCIENTIFIC DEMÉXICO, S.A. DE C.V.. The device was registered on February 04, 2020.
This page provides complete registration details including product type (II. PROSTHETICS, ORTHOSES AND FUNCTIONAL AIDS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
VERCISE GEVIAESTÁ INDICADOPARA SUUSOEN: -ESTIMULACIÓNUNILATERALOBILATERALDEL NÚCLEO SUBTALÁMICO (STN) O GLOBOPÁLIDOINTERNO(GPI)PARAENFERMEDADDEPARKINSON RESPONSIVA A LEVODOPA NOCONTROLADA ADECUADAMENTE CONMEDICACIÓN. - ESTIMULACIÓN UNILATERAL OBILATERALDELNÚCLEOSUBTALÁMICO(STN)OGLOBOPÁLIDOINTERNO(GPI)PARADISTONIAPRIMARIA Y SECUNDARIA INTRATABLE, PARAPERSONAS A PARTIR DE 7 AÑOS. -ESTIMULACIÓNTALÁMICAPARALASUPRESIÓNDE TEMBLOR CONTROLADOINADECUADAMENTE.
VERCISE GEVIA IS INDICATED FOR SUUSOIN: -UNILATERAL BILATERAL STIMULATION OF THE SUBTHALAMIC NUCLEUS (STN) OR GLOBOPALLIDUS INTERNAL (PG) FOR LEVODOPA-RESPONSIVE PARKINSON'S DISEASE NOT ADEQUATELY CONTROLLED WITH MEDICATION. - UNILATERAL OR BILATERAL STIMULATION OF THE SUBTHALAMIC NUCLEUS (STN) OR INTERNAL GLOBOPALLID (GPI) FOR INTRACTABLE PRIMARY AND SECONDARY PARADYSTONIA, FOR PEOPLE FROM 7 YEARS OLD. -THALAMIC STIMULATION FOR THE SUPPRESSION OF INADEQUATELY CONTROLLED TREMOR.